Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GRNA | Stock Option (Right to Buy) | Award | +236K | 236K | Feb 2, 2022 | Common Stock | 236K | $1.23 | Direct | F1, F2 | |||
transaction | GRNA | Stock Option (Right to Buy) | Award | +3.69K | 3.69K | Feb 2, 2022 | Common Stock | 3.69K | $1.23 | Direct | F2, F3 | |||
transaction | GRNA | Stock Option (Right to Buy) | Award | +66.6K | 66.6K | Feb 2, 2022 | Common Stock | 66.6K | $2.61 | Direct | F2, F4 |
Id | Content |
---|---|
F1 | 25% of the shares underlying the option vested or shall vest on July 17, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting August 17, 2021. |
F2 | This option was issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company. |
F3 | 25% of the shares underlying the option vested on July 17, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting August 17, 2021. |
F4 | 25% of the shares underlying the option vested or shall vest on June 30, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting July 30, 2022. |